Drug Profile
Research programme: calcitonin gene-related peptide therapeutics - Fortress Biotech
Alternative Names: CGRP - Fortress BiotechLatest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Fortress Biotech
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for preclinical development in Unspecified in USA
- 15 Nov 2016 Preclinical trials in Undefined indication in USA (unspecified route)